Which Weight Management Injection Offers Better Value?
Wegovy 1mg vs Mounjaro: Understanding the UK's Best Value Options
When comparing Wegovy 1mg vs Mounjaro for weight management, price often becomes a deciding factor for UK patients. At EverydayMeds, we've structured our pricing to offer the most transparent and competitive rates in the UK market. Wegovy 1mg, representing weeks 9-12 of your dose escalation journey, costs £99.99 and includes full clinical assessment, prescriber review, and next-day cold-chain delivery. This represents excellent value considering the comprehensive service package and genuine Novo Nordisk medication you receive.
Mounjaro offers a different value proposition through its dual-hormone mechanism, targeting both GLP-1 and GIP receptors simultaneously. While pricing structures differ between these treatments, both represent significant investments in long-term weight management that require careful consideration of cost versus potential benefits. Our clinical team can help you understand which option aligns best with your budget and weight management goals, ensuring you make an informed decision based on both clinical suitability and financial considerations.
Transparent Pricing Comparison: Wegovy 1mg vs Mounjaro Costs
EverydayMeds offers the UK's most transparent pricing for both Wegovy 1mg and Mounjaro treatments. Our Wegovy 1mg prescription costs £99.99, with new customers using discount code FIRST40 and returning patients applying code DOSE25 at checkout to access these rates. We also offer convenient bundling options, including our Advance Duo (1mg + 1.7mg) for £269.99, perfect for patients transitioning from week 9 to week 13 of their treatment protocol. These bundles provide supply continuity without the need for multiple orders and assessments.
When comparing Wegovy 1mg vs Mounjaro pricing, it's essential to consider the complete package rather than just medication costs. Both treatments require ongoing clinical oversight, cold-chain storage, and careful dose management. Our pricing includes comprehensive clinical assessment, MHRA-compliant prescriber review, and temperature-controlled next-day delivery. Unlike some competitors, we don't charge separate consultation fees or delivery costs, making our transparent pricing structure particularly attractive for patients managing monthly treatment budgets.
Clinical Evidence: Wegovy 1mg vs Mounjaro Trial Results
The clinical evidence supporting Wegovy comes primarily from the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). Patients using Wegovy 1mg during weeks 9-12 typically begin experiencing more pronounced appetite regulation and satiety effects. The SELECT cardiovascular outcomes trial also showed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
Mounjaro's clinical evidence derives from the SURMOUNT trial series, which evaluated its dual GIP/GLP-1 receptor agonist mechanism in weight management populations. When comparing Wegovy 1mg vs Mounjaro clinical data, it's important to note that trials used different methodologies, patient populations, and endpoints, making direct comparison inappropriate. Both treatments demonstrated significant weight management potential in clinical settings, though individual responses vary considerably and depend on adherence to prescribed lifestyle modifications.
How Wegovy 1mg Works in Your Weight Management Journey
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines after eating. This prescription-only medicine works by binding to GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. During the 1mg phase (weeks 9-12), many patients report more consistent appetite control and reduced food cravings compared to earlier dose levels. The medication also slows gastric emptying, helping you feel satisfied longer after meals and supporting adherence to reduced-calorie eating plans. This mechanism operates continuously throughout the week following your once-weekly injection, providing sustained appetite regulation that supports long-term weight management goals.
Simple Ordering Process for Wegovy 1mg and Mounjaro
Accessing either Wegovy 1mg or Mounjaro through EverydayMeds follows our streamlined three-step process designed for convenience and clinical safety. Begin with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any contraindications. Our MHRA-approved prescribing team reviews your assessment within 3 working days (or 24 hours with express service), ensuring clinical appropriateness and safety before authorising your prescription. Once approved, we dispatch your medication via next-day delivery using specialised cold-chain logistics to maintain temperature integrity. Our GPhC-registered pharmacy (#9012878) ensures every order meets pharmaceutical standards and includes detailed administration instructions. This process applies equally whether you're ordering Wegovy 1mg, Mounjaro, or switching between treatments under clinical guidance.
Storage and Practical Considerations: Wegovy 1mg vs Mounjaro
Both Wegovy 1mg and Mounjaro require refrigerated storage at 2-8°C before first use, but their room temperature tolerances differ significantly. Wegovy offers superior travel convenience, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. Wegovy comes in Novo Nordisk's FlexTouch pen system, providing precise 1mg dosing with an intuitive injection mechanism suitable for once-weekly administration. The pen design includes dose memory and injection confirmation features, reducing administration errors common with multi-dose devices. Both medications require gradual dose escalation following specific protocols, with Wegovy 1mg representing the third escalation step in a carefully designed progression toward the 2.4mg maintenance dose.
Cost-Effectiveness Analysis: Wegovy 1mg vs Mounjaro Long-term Value
When evaluating Wegovy 1mg vs Mounjaro for long-term cost-effectiveness, consider the complete treatment pathway rather than individual dose pricing. Wegovy's structured escalation protocol from 0.25mg through 2.4mg provides predictable monthly costs, with our bundle options offering supply security and convenience. The 1mg dose represents a crucial midpoint where many patients experience significant appetite changes, potentially reducing food costs and supporting adherence to treatment protocols. Our Advance Duo bundle bridges the transition from 1mg to 1.7mg for £269.99, eliminating the uncertainty of separate orders during this critical period.
Mounjaro's value proposition centres on its dual-hormone mechanism potentially offering enhanced efficacy for some patients, though individual response patterns vary significantly. Both treatments represent substantial monthly investments requiring budget planning and consideration of insurance or healthcare coverage options. EverydayMeds' transparent pricing eliminates surprise costs, with all fees included in our published rates and discount codes clearly explained for both new (FIRST40) and returning (DOSE25) customers accessing either treatment option.
Making Your Decision: Wegovy 1mg vs Mounjaro Selection Guide
Choosing between Wegovy 1mg and Mounjaro involves balancing clinical factors, cost considerations, and personal preferences regarding treatment approach. Both treatments are available through EverydayMeds with identical service standards, clinical oversight, and delivery arrangements, allowing you to focus on the medical aspects of your decision. Our clinical team can help you understand how your medical history, previous weight management attempts, and current health status influence treatment suitability. Consider discussing your budget constraints openly during consultation, as this affects long-term adherence and treatment success. The prescription-only nature of both medications ensures you receive expert guidance tailored to your individual circumstances, with ongoing monitoring available throughout your weight management journey. Remember that both treatments require commitment to lifestyle modifications including reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
